Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Sorafenib and Dacarbazine in Soft Tissue Sarcoma

NCT00837148 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT00837148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00837148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Sorafenib and Dacarbazine in Soft Tissue Sarcoma
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2009
Completion date
November 30, 2013
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leiomyosarcoma, malignant peripheral nerve sheath tumor, sarcoma, synovial sarcoma